Page 27 - மைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India s Covid-19 vaccination dry run in numbers: 286 sessions, 1 1 lakh vaccinators trained on Day 1

India s Covid-19 vaccination dry run in numbers: 286 sessions, 1.1 lakh vaccinators trained on Day 1 All the state and district officials were trained on the Operational Guidelines and for conducting the dry-run (Photo: PTI) 3 min read More than 75 lakh beneficiaries have been registered on Co-WIN software till date ahead of Covid-19 vaccine roll out in the country The preparation to handle any Adverse Events Following Immunization (AEFI) at all session sites and functionality of the Call Centers was also tested Share Via Read Full Story India today carried out a nationwide Covid-19 vaccine dry run as the country moves closer to begin its massive Covid-19 vaccination roll out for the general public.

Uttar pradeshHong kongHarsh vardhanOxford astrzeneca covidYogi adityanathSourav gangulyUnion healthDistrict hospital medical collegeHealth facilityCentral drugs standards control organisationCall centersSerum institute of indiaSerum instituteBharat biotechVictoria harborNew year

Subject Expert Committee Okays AstraZeneca, Bharat Biotech Vaccine Pitches

Subject Expert Committee Okays AstraZeneca, Bharat Biotech Vaccine Pitches 02/01/2021 The AstraZeneca logo is displayed on a screen at the NYSE, April 2019. Photo: Reuters/Brendan McDermid/File Photo. New Delhi: Experts at India‘s drugs regulator have recommended for emergency use two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other backed by a state-run institute, the government said on Saturday. A government minister said earlier the AstraZeneca/Oxford vaccine had been given the green light on Friday, paving the way for a huge immunisation campaign in the world’s second most populous country. The government said the final decision on the two vaccines would be made by the chief of the Central Drugs Standards Control Organisation (CDSCO). That process is expected to be a formality given the urgency for a vaccine in the country with the highest number of COVID-19 infections in the world after the United States.

United kingdomUnited statesNew delhiAstrazeneca oxfordZydus cadila zycoNarendra modiPrakash javadekarSubramanian swamyIndian council of medical researchPfizer incCentral drugs standards control organisationSerum institute of indiaOxford universityBharat biotechIndian councilBroadcasting minister prakash javadekar

Homegrown Covaxin gets expert committee s nod, some experts fear international backlash

Homegrown Covaxin gets expert committee s nod, some experts fear international backlash
newindianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newindianexpress.com Daily Mail and Mail on Sunday newspapers.

United kingdomZydus cadillaSumi sukanya duttaBoris johnsonNational institute of virologyAstrazeneca oxford universityCentral drugs standards control organizationWorld health organizationNews serviceSerum institute of indiaExpert committeeBharat biotechNational instituteSubject expert committeeDrugs controller generalSerum institute

India s drug regulator s expert body recommends two Covid-19 vaccines for emergency use

The Subject Expert Committee of Central Drugs Standards Control Organization (CDSCO) met for two days today and yesterday and recommended that the Drugs Controller General of India (DCGI) grant permission for restricted emergency use of the Oxford-AstraZeneca vaccine, subject to multiple regulatory conditions to the Serum Institute of India based in Pune city, the health ministry said in a statement. The committee also granted permission to Bharat Biotech for restricted use of Covaxin in emergency situation in public interest as an abundant precaution in clinical trial mode , especially in the context of infection by mutant strains, the statement also said.

Cadila healthcare ltdSerum institute of indiaBharat biotechSerum instituteSubject expert committeeCentral drugs standards control organizationDrugs controller generalகாடிலா சுகாதாரம் லிமிடெட்சீரம் நிறுவனம் ஆஃப் இந்தியாபாரத் பயோடெக்சீரம் நிறுவனம்பொருள் நிபுணர் குழுமைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந்மருந்துகள் கட்டுப்படுத்தி ஜநரல்

India likely to approve two-dose regimen for COVID vaccines, 4 weeks apart

India likely to approve two-dose regimen for COVID vaccines, 4 weeks apart
thesundaily.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thesundaily.my Daily Mail and Mail on Sunday newspapers.

Astrazeneca oxfordKrishnan dasShilpa jamkhandikarDavid evansBharat biotechCentral drugs standards control organisationகிருஷ்ணன் தாஸ்டேவிட் எவன்ஸ்பாரத் பயோடெக்மைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந்